AU4308699A - Use of anti-prolactin agents to treat proliferative conditions - Google Patents

Use of anti-prolactin agents to treat proliferative conditions

Info

Publication number
AU4308699A
AU4308699A AU43086/99A AU4308699A AU4308699A AU 4308699 A AU4308699 A AU 4308699A AU 43086/99 A AU43086/99 A AU 43086/99A AU 4308699 A AU4308699 A AU 4308699A AU 4308699 A AU4308699 A AU 4308699A
Authority
AU
Australia
Prior art keywords
proliferative conditions
treat proliferative
prolactin
agents
prolactin agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU43086/99A
Inventor
Wen Y Chen
Thomas E. Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Greenville Hospital System
Original Assignee
Greenville Hospital System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greenville Hospital System filed Critical Greenville Hospital System
Publication of AU4308699A publication Critical patent/AU4308699A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2257—Prolactin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU43086/99A 1998-05-12 1999-05-12 Use of anti-prolactin agents to treat proliferative conditions Withdrawn AU4308699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8512898P 1998-05-12 1998-05-12
US60085128 1998-05-12
PCT/US1999/010545 WO1999058097A2 (en) 1998-05-12 1999-05-12 Use of anti-prolactin agents to treat proliferative conditions

Publications (1)

Publication Number Publication Date
AU4308699A true AU4308699A (en) 1999-11-29

Family

ID=22189638

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43086/99A Withdrawn AU4308699A (en) 1998-05-12 1999-05-12 Use of anti-prolactin agents to treat proliferative conditions

Country Status (2)

Country Link
AU (1) AU4308699A (en)
WO (1) WO1999058097A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1959985B1 (en) * 2005-10-20 2009-10-14 Ghc Research Development Corporation Use of prolactin in the prophylactic treatment of cancer
US8008035B2 (en) 2007-01-25 2011-08-30 Roche Diagnostics Operations, Inc. Enhancement of vanadium-containing phosphatase inhibitors
EP1949894B1 (en) * 2007-01-25 2016-06-29 Roche Diagnostics GmbH Enhancement of vanadium-containing phosphatase inhibitors by polyols

Also Published As

Publication number Publication date
WO1999058097A2 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
AU2072201A (en) Agents and methods for the treatment of proliferative diseases
AU5675099A (en) Use of zeranol to modulate reproductive cycles
PL340589A1 (en) Derivatives of thienepyrimidine and thienepyridine useful as anticarcinogenic agents
AU1920900A (en) Solid water treatment composition and methods of preparation and use
PL333918A1 (en) Derivatives of 6-phenylpyryidil-2-amine useful as nos inhibitors
IL138129A (en) Composition for therapy of estrogen-associated disorders
PL330235A1 (en) Derivatives of spiropiperidine and their application as therapeutic agents
AU2212299A (en) Compositions and methods for the treatment of tumor
AU7582398A (en) Composition for treating skin conditions
AU7880700A (en) Compositions and methods of treatment for skin conditions using extracts of turmeric
AU6721598A (en) Dioxino derivatives and their use as therapeutic agents
AU7165798A (en) Use of genistein and related compounds to treat certain sex hormone related conditions
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
AU5800399A (en) Polish composition and method of use
AU3124300A (en) Inhibitors of beta-lactamases and uses therefor
AU5042000A (en) Methods of treating proliferative disorders
AU2190400A (en) Inhibitors of beta-lactamases and uses therefor
AU1969800A (en) Combination of active agents
AU2111399A (en) Wear reducing compositions and methods for their use
AU5056099A (en) Compounds for use in the treatment of inflammation
AU6917400A (en) Use of 5-ht1b/1d agonists to treat otic pain
AU2683899A (en) The use of bjerknes forces to manipulate contrast agents
AUPP010397A0 (en) Method and composition for treatment of sexual dysfunction
AU4981199A (en) Compositions and methods for modulating sexual activity
AU5509099A (en) Pyridinones for the treatment of sexual dysfunction

Legal Events

Date Code Title Description
MK13 Application withdrawn section 141(2)/reg 8.3(2) - pct appl. non-entering nat. phase, withdrawn by applicant